Innovative Medicines for Tuberculosis Foundation

Statistics

Publications

Citations

1.2K

Authors

Location

Lausanne, Switzerland

Also known as iM4TB Foundation

Innovative Medicines for Tuberculosis Foundation is a other institution in Lausanne, Switzerland known for pharmacy, tuberculosis pharmacotherapy, and drug discovery.

Homepage ROR

Top concepts

PharmacyPharmacologyDrug DiscoveryMedicinal ChemistryDrug DesignLigand BindingEnzyme InhibitionKinase InhibitorsLead OptimizationChemical Library Design

Publications

Leads for antitubercular compounds from kinase inhibitor library screens

Sophie Magnet, Ruben C. Hartkoorn, Rita Székely et al. · Tuberculosis · 2010 · 104 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)

Andréanne Lupien, Anthony Vocat, Caroline S. Foo et al. · Antimicrobial Agents and Chemotherapy · 2018 · 65 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma

Dany Spaggiari, Vincent Desfontaine, S. Cruchon et al. · PLoS ONE · 2019 · 20 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Raising awareness of the importance of funding for tuberculosis small-molecule research

Giovanna Riccardi, Iain G. Old, Sean Ekins · Drug Discovery Today · 2016 · 16 citations

Pharmacy, Medicinal Chemistry, Microbiology +11

1–4 of 7

Authors

MB
Manuel Bueno
Innovative Medicines for Tuberculosis Foundation, Switzerland
3 publications · 300 citations
2
h-index
JP
Jeff Pitteloud
Innovative Medicines for Tuberculosis Foundation, Switzerland
1 publications · 20 citations
1
h-index

1–2 of 2